LioniX joins project on integrated photonics for point-to-point laser broadband
We’re excited to be supporting a new joint project to develop superfast wireless optical communication.
Optical beamforming success heralds responsive broadband networks
Broadband mobile networks that respond to localized demand are a step closer thanks to wireless communications technology reported by LioniX International and partners this month.
Celebrating the International Day of Women and Girls in STEM
To mark the International Day of Women and Girls in Stem today some of our women engineers and scientists took some time out to reflect on what they find exiting about working in STEM.
LioniX International is 20 this week!
This week marked our 20th anniversary. We looked back with pride at 20 years of innovation and technology leadership in integrated photonics and customized microsystems solutions.
Low error data transmission with an integrated photonic optical equalizer
Devices to support ultra-fast data-transmission could be possible thanks to a novel optical equalizer fabricated by LioniX International.
A photonic integrated ion trap for scalable quantum computing
A photonic integrated ion trap fabricated by LioniX International is rivalling the most sophisticated experiments.
LioniX International in €19 million innovation hub
LioniX International is participating in a new €19 million European hub to increase access to photonics technology for small and medium sized enterprises.
Accelerated development of fast and reliable COVID-19 test
Lionix International and other leading Dutch biochip companies accelerate development of fast and reliable COVID-19 test.
LioniX International appoints Arne Leinse as new CEO
On December 3, 2019 LioniX International has appointed Arne Leinse as the new CEO as of January 1st 2020. LioniX International is the leading global provider of customized microsystem solutions, in particular integrated photonics-based, in scalable production volumes.
Leading Dutch alliance in biochip development
As of April 15, 2019, Qurin Diagnostics B.V. and Lionix International B.V. have acquired Surfix B.V. As a supplier of custom-made nanocoatings, the capabilities of Surfix are highly complementary to the products and services offered by Qurin and LioniX International. The companies are already working together closely on early cancer detection and have realized a sensitive biochip, bringing together their respective complementary technologies for this purpose. This acquisition strengthens their relationship and mutual commitment towards bringing this technology to the global biomedical market. Read the complete press release